Table 3.
Clinical, demographical, and laboratory data of the groups
| Early discharge (n=113) (21.1%) | Late discharge (n=108) (48.9%) | All patients (n=221) (100%) | p | |
|---|---|---|---|---|
| Age | 57.4±19.9 (18–89) | 70.0±13.6 (39–94) | 63.6±18.3 (20–92) | <0.001 |
| Male (%) | 82 (72.6) | 74 (68.5) | 74 (70.5) | 0.509 |
| Hemoglobin (gr/dl) | 9.0±2.2 (5.1–16.6) | 8.5±2.4 (3.7–15.5) | 8.8±2.3 (3.7–16.6) | 0.073 |
| White blood cell (x103) | 9.3±3.9 | 12.4±7.8 | 10.8±6.3 | <0.001 |
| Tachycardia (%) | 44 (38.9) | 68 (63) | 112 (50.7) | <0.001 |
| Hypotension (%) | 20 (17.7) | 22 (20.4) | 42 (19) | 0.613 |
| Mean number of erythrocyte suspension transfusions | 1.7±1.5 (0–6) | 3.9±4.1 (0–21) | 2.8±3.2 | <0.001 |
| Length of stay in intensive care unit (days) | 0.8±1.1 (0–3) | 3.9±5.3 (0–28) | 2.3±4.1 (0–28) | <0.001 |
| Hospitalization (days) | 3.3±0.8 (1–5) | 10.1±8.2 (11–55) | 6.6±6.7 (1–55) | <0.001 |
| Glasgow-Blatchford Score | 10.8±3.3 (4–17) | 12.6±2.8 (7–19) | 11.7±3.2 (4–19) | <0.001 |
| Rockall Score | 5.0±1.9 (2–9) | 6.0±1.9 (2–10) | 5.5±2.0 (2–10) | <0.001 |
| Neutrophil lymphocyte ratio | 4.1±1.6 | 5.5±2.9 | 4.8±2.4 | <0.001 |
| Platelet lymphocyte ratio | 178.2±101.9 | 151.6±82.7 | 165.2±93.8 | 0.035 |
| Presence of chronic renal disease (%) | 13 (11.5) | 13 (12) | 26 (11.8) | 0.902 |
| Presence of diabetes mellitus (%) | 10 (8.8) | 29 (26.9) | 39 (17.6) | <0.001 |
| Presence of coronary artery disease (%) | 28 (24.8) | 43 (39.8) | 71 (32.1) | 0.017 |